Peter N. Pferschy

Empagliflozin in acute myocardial infarction: the EMMY trial

Dirk von Lewinski, Ewald Kolesnik, Norbert J. Tripolt et al. · European Heart Journal · 2022 · 290 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Efficacy and Safety of Intermittent Fasting in People With Insulin-Treated Type 2 Diabetes (INTERFAST-2)—A Randomized Controlled Trial

Anna Obermayer, Norbert J. Tripolt, Peter N. Pferschy et al. · Diabetes Care · 2022 · 106 citations · Full text

Medicine, Endocrinology, Nutrition +17

Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction—The EMMY trial

Norbert J. Tripolt, Ewald Kolesnik, Peter N. Pferschy et al. · American Heart Journal · 2019 · 72 citations

Medicine, Cardiology, Pharmacology +15

Humoral immune response to <scp>COVID‐19</scp> vaccination in diabetes is age‐dependent but independent of type of diabetes and glycaemic control: The prospective <scp>COVAC‐DM</scp> cohort study

Caren Sourij, Norbert J. Tripolt, Faisal Aziz et al. · Diabetes Obesity and Metabolism · 2022 · 64 citations · Full text

Veterinary Medicine, Immunology, Clinical Immunology +16

Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial

Othmar Moser, Max L. Eckstein, Alexander Mueller et al. · Diabetic Medicine · 2019 · 38 citations · Full text

Education, Endocrinology, Physiology +17